Asymchem to Repurchase and Cancel 61,000 Restricted A Shares After Staff Resignations

Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( (HK:6821) ) has issued an update.

Asymchem Laboratories (Tianjin) Co., Ltd. has approved the repurchase and cancellation of 61,000 restricted A shares previously granted under its 2025 A Share restricted share incentive scheme to five employees who have since resigned. In line with the scheme’s terms, these not-yet-unlocked shares will be bought back at adjusted grant prices using internal funds, causing a marginal reduction in total A share capital and a slight change in the proportion of A and H shares outstanding.

Following the transaction, the number of incentive participants under the initial and reserved grants will be trimmed by a total of five, and the aggregate restricted A shares under the scheme will be slightly reduced. While the move has minimal impact on overall share capital, it reflects routine administration of the incentive plan and a modest tightening of the company’s equity-based compensation pool, with limited direct implications for existing shareholders.

The most recent analyst rating on (HK:6821) stock is a Hold with a HK$90.00 price target. To see the full list of analyst forecasts on Asymchem Laboratories (Tianjin) Co., Ltd. Class H stock, see the HK:6821 Stock Forecast page.

More about Asymchem Laboratories (Tianjin) Co., Ltd. Class H

Asymchem Laboratories (Tianjin) Co., Ltd. is a China-based pharmaceutical services company listed in Hong Kong that operates in the contract development and manufacturing organization (CDMO) segment. The company focuses on providing research, development, and manufacturing services for pharmaceutical products, serving both domestic and international drug developers through its A share and H share listings.

Average Trading Volume: 304,276

Technical Sentiment Signal: Buy

Current Market Cap: HK$39.55B

See more insights into 6821 stock on TipRanks’ Stock Analysis page.